19 Jun 2019
Posted in Pharma
Negative attitudes towards vaccines means European childhood vaccine market will remain at $1.2bn to 2028
Following the news that a number of people have low confidence in vaccination, James Mather, Senior Pharma Analyst at GlobalData, a leading data and analytics company offers his view on what this means for the vaccine markets:
“Results from a large study conducted by the Wellcome Trust add to the growing body of evidence that mistrust in vaccine effectiveness and safety is responsible for increasingly concerning vaccination rates.
“Stubbornly low vaccination rates paired with decreasing birth rate will see the pediatric combination vaccines market, across France, Germany, Italy, Spain and the UK, slowly contract from $1.22bn in 2018, at a negative compound annual growth rate (CAGR) of 0.3%, to a value $1.18bn by 2028, according to GlobalData.
“Despite the recent influx of government initiatives being proposed throughout Europe, the continuing negative attitudes towards vaccine safety and efficacy will have a detrimental effect on the European vaccine markets.”